Back to VANGUARD GROUP INC VANGUARD GROUP INC

INKTINKT
4 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in MINK THERAPEUTICS INC

As of its last 13F, for Q4 2025, Vanguard Group held 67,651 shares of INKT (Mink Therapeutics), worth $754,309. It increased the position by 34,300 shares (+102.9%) from Q3 2025. Vanguard Group held INKT from Q1 2025 to Q4 2025, across 4 quarterly 13F filings.

Current Value

$754,309

Current Shares

67,651

Total Value Change

+$549,161

Total Shares Change

+43,907

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
67,651
+102.8%
$754,3090.0%$11.15
27
2025-Q3
Increased
33,351
+40.5%
$466,9140.0%$14.00
22
2025-Q2
Unchanged
23,744
0.0%
$177,6050.0%$7.39
0
2025-Q1
New
23,744
-
$205,1480.0%$8.64
35

Other major holders of INKT: VANGUARD CAPITAL MANAGEMENT LLC, DnB Asset Management AS, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used